stent thrombosis

The Debate Over Clopidogrel Continues

January 30, 2012
Genetics impacts how quickly people metabolize the commonly prescribed anti-clotting drug clopidogrel (Plavix), but whether genetics affects cardiovascular outcomes of people taking the drug is a subject of debate.
Read More